RPE65 and Alzheimer disease: Here, we describe the discovery, replication, clinical, molecular and functional characterization of a novel AD RPE65-related retinopathy in multiple families in Europe and North America due to a Belgian founder variant c.1555G>A, p.(Glu519Lys), hereafter referred to as p.(E519K).